Samir Kaul - 15 Jun 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John J. Demeter, as attorney-in-fact for Samir Kaul
Issuer symbol
GH
Transactions as of
15 Jun 2022
Transactions value $
$0
Form type
4
Filing time
17 Jun 2022, 17:54:57 UTC
Previous filing
03 Jun 2022
Next filing
11 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +1,814 +45% $0 5,873 15 Jun 2022 Direct
holding GH COMMON STOCK 4,943 15 Jun 2022 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -1,814 -100% $0* 0 15 Jun 2022 COMMON STOCK 1,814 $0 Direct F2, F3
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +8,789 $0 8,789 15 Jun 2022 COMMON STOCK 8,789 $38.42 Direct F4
transaction GH RESTRICTED STOCK UNITS Award $0 +5,531 $0 5,531 15 Jun 2022 COMMON STOCK 5,531 $0 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.
F2 The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022.
F3 Not applicable for Restricted Stock Units.
F4 The Stock Options vest in full on the one-year anniversary of the grant date, June 15th, 2023.
F5 The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2023.